Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EnBio Holdings (TSE:6092) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
EnBio Holdings Forward PE Ratio Related Terms
EnBio Holdings Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for EnBio Holdings's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EnBio Holdings Forward PE Ratio Chart
EnBio Holdings Annual Data
Trend
Forward PE Ratio
EnBio Holdings Quarterly Data
Forward PE Ratio
TSE:6092 vs CTAS, CPRT, GPN: Forward PE Ratio Comparison
For the Specialty Business Services subindustry, EnBio Holdings's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings Forward PE Ratio vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
EnBio Holdings (TSE:6092) has a Forward PE Ratio of 0.00 as of Aug. 24, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on EnBio Holdings and its competitors. According to the industry distribution chart, EnBio Holdings ranks #999999 out of 416 companies in the Business Services industry.
Is EnBio Holdings' Forward PE Ratio too high?
EnBio Holdings' current Forward PE Ratio is 0.00. Based on the distribution chart, EnBio Holdings ranks #999999 out of 416 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' Forward PE Ratio compare to CTAS and CPRT?
According to the Business Services industry distribution chart, EnBio Holdings ranks #999999 out of 416 companies for Forward PE Ratio. This places EnBio Holdings in the lower half of its industry. The industry median Forward PE Ratio is 13.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Business Services company?
The median Forward PE Ratio among Business Services companies is 13.23, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on EnBio Holdings and its competitors. For the Business Services industry, the median Forward PE Ratio is 13.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EnBio Holdings's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円806.27, compared to a current price of 円862.00 — trading 6.9% above its estimated fair value. The current Forward PE Ratio is 0.00. EnBio Holdings' overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current Forward PE Ratio is 0.00 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be overvalued.
The current stock price of 円862.00 is trading 6.9% above its estimated GF Value™ of 円806.27.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
Forward PE Ratio: 0.00
GF Value™: 円806.27 vs. price of 円862.00 (6.9% above fair value)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score
Get the complete analysis for TSE:6092
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
